Sofia Michael J.
Officer at ABUS
- Sold, on record
- $1.7M
- Dollars the filings state
- Form 4 sales
- 8
- Latest Feb 2, 2024
- Form 144 notices
- 5
- Proposed sales
- Companies
- 1
- Filed as an executive or holder
Companies
- ABUSArbutus Biopharma CorpOfficer
Sales by reason
Form 4 sales per month, last 12 months.
Timeline
- 1 Form 4 sale ABUSPlan not statedAug 13, 2018 2018
Sold 4,250 shares at $9.51 ($40k)
Sofia Michael J., Chief Scientific Officer
Sold 0.3% of holdings ($14.3M position)1.5M shares left0.2x usual sizeFiling
- 2 Form 4 sale ABUSPlan not statedDec 1, 2021 +1206 days
Sold 200,000 shares at $5.09 ($1M)
Sofia Michael J., Chief Scientific Officer
Sold 13.3% of holdings ($7.7M position)1.3M shares leftFirst sale on recordFiling
- 3 Form 4 sale ABUSRoutineFeb 2, 2024 +793 days
Sold 9,982 shares at $2.31 ($23k)
Sofia Michael J., Chief Scientific Officer
10b5-1 planSold 0.7% of holdings ($3.5M position)1.5M shares leftFirst sale on recordFiling
- 4 Form 144 notice ABUSNoticeMar 7, 2025 +399 days
Filed to sell 167,162 shares ($550k)
Sofia Michael J., Member of immediate family of any of the foregoing
No 10b5-1 planFiling
- 5 Form 144 notice ABUSNoticeMar 13, 2025 +6 days
Filed to sell 100,000 shares ($338k)
Sofia Michael J., Officer
No 10b5-1 planFiling
- 6 Form 144 notice ABUSNoticeMar 19, 2025 +6 days
Filed to sell 150,000 shares ($480k)
Sofia Michael J., Officer
No 10b5-1 planFiling
- 7 Form 144 notice ABUSNoticeMar 24, 2025 +5 days
Filed to sell 250,000 shares ($820k)
Sofia Michael J., Officer
No 10b5-1 planFiling
- 8 Form 144 notice ABUSNoticeMar 31, 2025 +7 days
Filed to sell 250,000 shares ($875k)
Sofia Michael J., Officer
No 10b5-1 planFiling
Every transaction
Loading transactions…
Sales and notices (13)
| Source | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Mar 31, 2025 | Mar 31, 2025 | ABUS | Officer | Form 144 notice | 250,000 | $875k | Notice | SEC | |
| Mar 24, 2025 | Mar 24, 2025 | ABUS | Officer | Form 144 notice | 250,000 | $820k | Notice | SEC | |
| Mar 19, 2025 | Mar 19, 2025 | ABUS | Officer | Form 144 notice | 150,000 | $480k | Notice | SEC | |
| Mar 13, 2025 | Mar 13, 2025 | ABUS | Officer | Form 144 notice | 100,000 | $338k | Notice | SEC | |
| Mar 7, 2025 | Mar 7, 2025 | ABUS | Member of immediate family of any of the foregoing | Form 144 notice | 167,162 | $550k | Notice | SEC | |
| Feb 2, 2024 | Feb 5, 2024 | ABUS | Chief Scientific Officer | Form 4 sale | 9,982 | $23k | 0.7% | Routine | SEC |
| Dec 1, 2021 | Dec 3, 2021 | ABUS | Chief Scientific Officer | Form 4 sale | 200,000 | $1M | 13.3% | Plan not stated | SEC |
| Aug 13, 2018 | Aug 14, 2018 | ABUS | Chief Scientific Officer | Form 4 sale | 4,250 | $40k | 0.3% | Plan not stated | SEC |
| Jul 11, 2018 | Jul 13, 2018 | ABUS | Chief Scientific Officer | Form 4 sale | 10,000 | $100k | 0.7% | Plan not stated | SEC |
| Jul 9, 2018 | Jul 10, 2018 | ABUS | Chief Scientific Officer | Form 4 sale | 20,000 | $174k | 1.3% | Plan not stated | SEC |
| Jul 5, 2018 | Jul 6, 2018 | ABUS | Chief Scientific Officer | Form 4 sale | 20,000 | $164k | 1.3% | Plan not stated | SEC |
| Oct 3, 2017 | Oct 5, 2017 | ABUS | Chief Scientific Officer | Form 4 sale | 10,000 | $80k | 0.6% | Plan not stated | SEC |
| Aug 15, 2017 | Aug 17, 2017 | ABUS | Chief Scientific Officer | Form 4 sale | 30,000 | $111k | 14.9% | Plan not stated | SEC |